眼科 ›› 2025, Vol. 34 ›› Issue (4): 289-293.doi: 10.13281/j.cnki.issn.1004-4469.2025.04.007

• 论著 • 上一篇    下一篇

集中采购形势下白内障手术患者费用控制成本效果分析

赵熠  孟庆玲   

  1. 首都医科大学附属北京同仁医院,北京100730 
  • 收稿日期:2025-04-15 出版日期:2025-07-25 发布日期:2025-07-13
  • 通讯作者: 孟庆玲,Email:bjtrjjjc@163.com

Cost-effectiveness analysis of cost control for cataract surgery patients under the national centralized procurement policy#br#

Zhao Yi, Meng Qingling   

  1. Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2025-04-15 Online:2025-07-25 Published:2025-07-13
  • Contact: Meng Qingling, Email: bjtrjjjc@163.com

摘要:  目的  分析集中采购形势下白内障手术患者费用控制成本效果情况。设计  卫生经济学评价。研究对象  2024年1月-12月北京同仁医院眼科白内障摘除人工晶状体(IOL)植入术的住院患者,其中集中采购前患者18, 743例(18, 743眼)(集中采购前组),集中采购后患者19, 346例(19, 346眼)(集中采购后组)。方法  比较集中采购前后患者使用IOL的品牌规格及用量、例均住院各项费用。统计手术量排名前15的医生收治诊断相关分组(DRGs)付费患者的例均住院总费用、例均材料费用,与2024年北京市医保均值比较。主要指标  IOL使用量,患者例均住院总费用、例均材料费用。结果  集中采购后,单焦点IOL使用量下降39.29%,多焦点(含景深延长型)IOL使用率提升至44.84%;患者例均住院总费用下降647.83元,其中材料费用降幅达774.50元(22.29%),IOL费用降幅贡献占比超90%;手术量排名前15的医生中6位医师收治的患者的例均材料费低于北京市医保均值(下降比例0.96%~19.99%),11位医师收治的患者的例均住院总费用低于北京市医保均值(下降比例1.92%~20.99%)。结论  IOL国家集中采购政策出台后,通过与北京市医保实施DRGs付费改革政策联动机制,不仅有效实现了医疗费用的合理化控制,同时通过优化资源配置,使医疗服务在保障基础需求的基础上,更能响应白内障患者的个性化医疗需求。

关键词: 集中采购, 白内障, 人工晶状体, 卫生经济学

Abstract:  Objective To analyze the cost-control effectiveness of cataract surgery under the national centralized procurement policy. Design Health economics evaluation. Participants Hospitalized patients undergoing phacoemulsification with intraocular lens (IOL) implantation at Beijing Tongren Hospital from January to December, 2024, including 18,743 cases (18,743 eyes) before policy implementation (pre-procurement group) and 19,346 cases (19,346 eyes) after implementation (post-procurement group). Methods Compare and analyze the brand specifications, dosage, and average hospitalization expenses of IOL used by patients before and after centralized procurement. Compare the average total hospitalization cost and material cost per case of DRGs paid patients admitted by the top 15 doctors in terms of surgical volume with the average medical insurance cost in Beijing in 2024. Main Outcome Measures Utilization rates of monofocal and multifocal IOLs; per-case total hospitalization costs and material costs. Results Post-policy implementation: Monofocal IOL usage decreased by 39.29%, while multifocal (including extended depth-of-focus) IOL utilization rose to 44.84%. Per-case total hospitalization costs decreased by RMB 647.83, with material costs dropping RMB 774.50 (22.29%), of which over 90% was attributable to reduced IOL expenses. Among the top 15 surgeons, 6 achieved per-case material costs below Beijing’s average (0.96%-19.99% reduction) , and 11 achieved per-case total hospitalization costs below the average (1.92%-20.99% reduction). Conclusion  After the introduction of the national centralized procurement policy of IOL, through the implementation of the DRGs payment reform policy linkage mechanism with Beijing medical insurance, it not only effectively realized the rationalization control of medical expenses, but also optimized the allocation of resources, so that medical services can better respond to the personalized medical needs of cataract patients on the basis of ensuring the basic needs.

Key words:  Volume-based procurement, Intraocular lenses, Health economics